Clinical Trial Update: Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment [Phase 1]

View source ↗

Summary

Phase 1 feasibility study of DermGEN for diabetic foot ulcer treatment has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• DermGEN

Snippet

Sponsor: Dr. Paul F. Gratzer | Conditions: Diabetes Type I, Diabetes Type II | Phase 1 | Status: COMPLETED | Results posted: 2019-09-16